- Filed
- May 18, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 1.44M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 341.38K sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 58.08K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.36M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.1M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $2.82M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $814.04K |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.09M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.67M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $3.31M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $5.6M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $6.23M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.8M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $6.44M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $3.48M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $6.95M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $6.61M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $9.53M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$6.66 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$28.55 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$6.66 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$28.55 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $680.42K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $758.67K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.28M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.66M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2.54M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.64M |